Discrimination of changes in osteoporosis outcomes

Journal of Rheumatology

Volumn 28, Issue 2, 2001, Pages 413-421

  Cranney, A ^a   Welch, V ^a   Wells, G ^a   Adachi, J ^a   Shea, B ^a   Simon, L ^a   Tugwell, P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Discrimination; Minimal clinically important difference; Osteoporosis; Validity

Indexed keywords

BONE DENSITY; CLINICAL RESEARCH; CONFERENCE PAPER; DATA ANALYSIS; DISCRIMINANT ANALYSIS; DISEASE COURSE; HUMAN; INDIVIDUALIZATION; OSTEOPOROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOLOGY; VERTEBRA FRACTURE;

CLINICAL TRIALS; DATABASES, BIBLIOGRAPHIC; HUMANS; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE;

EID: 0035109448     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (67)

1. Implications of OMERACT outcomes in arthritis and osteoporosis for Cochrane metaanalysis
2. Responsiveness of endpoints in osteoporosis clinical trials
3. Responsiveness of endpoints in osteoporosis clinical trials - An update
4. Treatment of postmenopausal osteoporosis
5. Calcaneal ultrasonometry: Response to treatment in comparison with dual X-ray absorptiometry measurements of the lumbar spine and femur
6. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group
7. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people
8. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group
9. Which fractures are associated with low appendicular bone mass in elderly women?
10. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: The European Quantitation of Osteoporosis Study
11. Antifracture efficacy of antiresorptive agents are related to changes in bone density
12. Discordance in patient classification using T-scores
13. Diagnosis of osteoporosis and osteopenia by bone mineral density and content
14. Quantitative ultrasound measurements of the tibia and calcaneus in comparison with DXA measurements at various skeletal sites
15. Stiffness in discrimination of patients with vertebral fractures
16. Does combining the results from multiple bone sites measured by a new quantitative ultrasound device improve discrimination of hip fracture?
17. Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population
18. Overview of role of BMD measurements in managing osteoporosis
19. Interpretation of bone densitometry studies
20. Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women
21. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss
22. Individual smallest detectable difference in bone mineral density measurements
23. Smallest detectable difference in radiological progression
24. The impact of measurement error on the comparison of two treatments using a responder analysis
25. Preliminary definition of improvement in rheumatoid arthritis
26. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
27. Monitoring osteoporosis therapy with bone densitometry: Misleading changes and regression to the mean
28. Monitoring skeletal response to therapy in early postmenopausal women: Which bone to measure?
29. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study
30. A comparison of longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: The four year effects of hormone replacement therapy
31. Sources of variability in bone mineral density measurements: Implications for study design and analysis of bone loss
32. Patient responsiveness to calcitonin salmon nasal spray: A subanalysis of a 2-year study
33. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate
34. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group
35. A position paper of the European Foundation for Osteoporosis and Bone Disease
36. Vertebral fractures and mortality in older women
37. The association of radiographically detected vertebral fractures with back pain and function: A prospective study
38. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group
39. Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group
40. The impact of incident vertebral fracture on health related quality of life in established postmenopausal osteoporosis: Results from the Multiple Outcomes of Raloxifene Evaluation Study
41. Influence of fracture criteria on the outcome of a randomized trial of therapy
42. Defining incident vertebral deformity: A prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group
43. Outcome variables in osteoporosis trials [review]
44. The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial
45. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
46. Design of the Fracture Intervention Trial
47. Design of the Women's Health Initiative clinical trial and observational study
48. Economics in sample size determination for clinical trials
49. Quality of life in patients with vertebral fractures: Validation of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation of Osteoporosis
50. The impact on health related quality of life (HRQOL) in postmenopausal women with low BMD and prevalent fractures. American Society for Bone and Mineral Research
51. Reliability of an Osteoporosis-Targeted Quality of Life Survey Instrument for use in the community: OPTQoL
52. Development and validation of a discriminative quality of life questionnaire for osteoporosis (The OPRQoL)
53. Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis quality of life study group
54. Quality of life in patients with osteoporosis fractures: Cultural adaptation, reliability and validity of the Osteoporosis Assessment Questionnaire
55. Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use?
56. Spinal curvatures and quality of life in women with vertebral fractures secondary to osteoporosis
57. Health-related quality of life of Colles' fracture patients
58. The clinical impact of vertebral fractures: Quality of life in women with osteoporosis
59. Spinal deformity and mobility self-confidence among women with osteoporosis and vertebral fractures
60. A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture
61. Psychosocial functioning and osteoporosis in late life: Results of a multidisciplinary intervention
62. Reliability of physical performance tests in four different randomized clinical trials
63. A questionnaire to evaluate disability in osteoporotic patients with vertebral compression fractures. Series A. Biological Sciences & Medical Sciences
64. Impact of a 12-month exercise program on the physical and psychological health of osteopenic women
65. A weight-bearing, water-based exercise program for osteopenic women: Its impact on bone, functional fitness, and well-being
66. Functional impact of unvarying exercise program in women after menopause